Top revenue drugs 2013

Crohn's Disease Forum

Help Support Crohn's Disease Forum:

kiny

Well-known member
Joined
Apr 28, 2011
Messages
3,463
http://www.theguardian.com/business/table/2014/mar/27/world-best-selling-prescription-drugs-pharmaceuticals-industry

vghifl.jpg


New treatment for crohn's disease depends on these patents expiring, it is crucial that these patents expire or there will never be new treatment.

Janssens actually went to court to make sure their patent got an extension for paediatric so paediatric patients could not get different treatment.

Thier patents expire in a couple of months in many countries, it should allow for a more open market, where hopefully not a single drug can dominate the market and people actually research new drugs for crohn's disease.
 
Last edited:
Don't expect generics of biologics outside the EU. There is no official framework for dealing with them in the US and though there was an attempt to design one, it died in committee. I wouldn't be surprised if some nice men from Johnson & Johnson and/or Pfizer made sure such a thing didn't happen.

Many other countries also do not allow generic biologics, the most notable exception being India.
 
It's really outrageous they get to keep these patents so long. We desperately need more government involvement in the research arena.
 
Yeah I also don't see a generic biologic ever coming out. All the cell lines/procedures/etc. are proprietary. It's not like with most pharmaceuticals that you need knowledge of the chemical structure and you can synthesize it from scratch.
 
Yeah I also don't see a generic biologic ever coming out. All the cell lines/procedures/etc. are proprietary. It's not like with most pharmaceuticals that you need knowledge of the chemical structure and you can synthesize it from scratch.

If you live in India you can actually get generic Etanercept! So it's quite possible. The savings aren't as huge as they are with typical chemistry based medications but it's still a price drop of 30%!
 
The companies lobbied that because these drugs are so expensive to test, it costs too much for them to be worthwhile, unless they get to keep their patents indefinitely. This is nonsense, because them making their money back is the reason these drugs are exorbitantly expensive when compared to other drugs. Anyway here's an article about Obama "pushing" for less time for biologicals having exclusivity. Not surprisingly, the house is against it. (Please take this with a grain of salt though, I'm not sure how reliable a source GaBi is).
 
Back
Top